Portfolio of Soros Fund Management
Founded by George Soros, Soros Fund Management is a family office for the Soros family and the Open Society Foundations; known for macro investing.
Source: 13F filing with the US Securities and Exchange Commission dated May 15, 2024. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q1 2024. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 2.6B USD
- Positions
- 135
- Share of the ten largest
- 40.6%
The ten largest positions Q1 2024
- Alphabet Inc. (Class A) 8.8%▲ +22.3%
- Aercap Holdings NV 6.7%▼ −20.4%
- American Eqty Invt Life Hld 4.2%▲ +17.1%
- Novo Nordisk (ADR) 4.0%▼ −48.7%
- Cerevel Therapeutics Hldng I 3.2%new
- Liberty Broadband Corp 3.1%unchanged
- Amazon 2.8%▼ −29.0%
- CRH plc 2.7%▼ −45.6%
- Aramark 2.6%▲ +297.3%
- Booking Holdings 2.5%▲ +13.7%
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q1 2024
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| Cerevel Therapeutics Hldng I | 3.2% | 1,940,201 | 82.0M USD | new | Q1 2024 1 quarter |
| Okta Inc | 1.7% | 426,326 | 44.6M USD | new | Q1 2024 1 quarter |
| Westrock Co | 1.7% | 900,001 | 44.5M USD | new | Q1 2024 1 quarter |
| PCG PG&E Corporation | 1.4% | 2,117,354 | 35.5M USD | new | Q1 2024 1 quarter |
| RUN Sunrun | 1.1% | 2,080,941 | 27.4M USD | new | Q1 2024 1 quarter |
| AZN AstraZeneca | 1.1% | 400,000 | 27.1M USD | new | Q1 2024 1 quarter |
| Ishares TR | 1.0% | 245,000 | 26.7M USD | new | Q1 2024 1 quarter |
| Axonics Inc | 0.8% | 295,955 | 20.4M USD | new | Q1 2024 1 quarter |
| Gfl Environmental Inc | 0.8% | 580,336 | 20.0M USD | new | Q1 2024 1 quarter |
| NET Cloudflare | 0.7% | 185,356 | 17.9M USD | new | Q1 2024 1 quarter |
| Ishares TR | 0.6% | 675,000 | 16.2M USD | new | Q1 2024 1 quarter |
| AIG American International Group | 0.6% | 195,400 | 15.3M USD | new | Q1 2024 1 quarter |
| Matador Res Co | 0.6% | 225,000 | 15.0M USD | new | Q1 2024 1 quarter |
| Astera Labs Inc | 0.6% | 201,600 | 15.0M USD | new | Q1 2024 1 quarter |
| GS Goldman Sachs | 0.5% | 33,550 | 14.0M USD | new | Q1 2024 1 quarter |
| Biomarin Pharmaceutical Inc | 0.5% | 155,900 | 13.6M USD | new | Q1 2024 1 quarter |
| DHR Danaher Corporation | 0.5% | 50,000 | 12.5M USD | new | Q1 2024 1 quarter |
| Viper Energy Inc | 0.5% | 313,850 | 12.1M USD | new | Q1 2024 1 quarter |
| Aurora Innovation Inc | 0.5% | 4,250,000 | 12.0M USD | new | Q1 2024 1 quarter |
| Brightspring Health Svcs Inc | 0.5% | 1,101,554 | 12.0M USD | new | Q1 2024 1 quarter |
| FCX Freeport-McMoRan | 0.5% | 251,800 | 11.8M USD | new | Q1 2024 1 quarter |
| Argenx SE | 0.5% | 30,000 | 11.8M USD | new | Q1 2024 1 quarter |
| Rexford Indl Rlty Inc | 0.4% | 225,000 | 11.3M USD | new | Q1 2024 1 quarter |
| TD Synnex Corporation | 0.4% | 100,000 | 11.3M USD | new | Q1 2024 1 quarter |
| Howard Hughes Holdings Inc | 0.4% | 145,000 | 10.5M USD | new | Q1 2024 1 quarter |
| Springworks Therapeutics Inc | 0.4% | 203,946 | 10.0M USD | new | Q1 2024 1 quarter |
| Callon Pete Co Del | 0.3% | 250,000 | 8.9M USD | new | Q1 2024 1 quarter |
| Mp Materials Corp | 0.3% | 585,209 | 8.4M USD | new | Q1 2024 1 quarter |
| Sixth Street Specialty Lendi | 0.3% | 370,000 | 7.9M USD | new | Q1 2024 1 quarter |
| EW Edwards Lifesciences | 0.3% | 75,000 | 7.2M USD | new | Q1 2024 1 quarter |
| Kosmos Energy Ltd | 0.3% | 1,200,409 | 7.2M USD | new | Q1 2024 1 quarter |
| JPM JPMorgan Chase | 0.3% | 34,500 | 6.9M USD | new | Q1 2024 1 quarter |
| Invesco QQQ TR | 0.3% | 15,000 | 6.7M USD | new | Q1 2024 1 quarter |
| Pacific Biosciences Calif In | 0.2% | 1,633,000 | 6.1M USD | new | Q1 2024 1 quarter |
| DD DuPont | 0.2% | 72,804 | 5.6M USD | new | Q1 2024 1 quarter |
| MMM 3M | 0.2% | 50,000 | 5.3M USD | new | Q1 2024 1 quarter |
| GE GE Aerospace | 0.2% | 30,000 | 5.3M USD | new | Q1 2024 1 quarter |
| Sage Therapeutics Inc | 0.2% | 275,000 | 5.2M USD | new | Q1 2024 1 quarter |
| Helix Acquisition Corp II | 0.2% | 475,000 | 4.9M USD | new | Q1 2024 1 quarter |
| CARR Carrier Global | 0.2% | 84,716 | 4.9M USD | new | Q1 2024 1 quarter |
| Arcadium Lithium PLC | 0.2% | 1,000,000 | 4.3M USD | new | Q1 2024 1 quarter |
| Soleno Therapeutics Inc | 0.2% | 100,000 | 4.3M USD | new | Q1 2024 1 quarter |
| Digitalocean HLDGS Inc | 0.2% | 104,383 | 4.0M USD | new | Q1 2024 1 quarter |
| SPDR Ser TR | 0.2% | 35,000 | 3.9M USD | new | Q1 2024 1 quarter |
| Canadian Nat Res Ltd | 0.1% | 50,000 | 3.8M USD | new | Q1 2024 1 quarter |
| Suncor Energy Inc New | 0.1% | 100,000 | 3.7M USD | new | Q1 2024 1 quarter |
| Aar Corp | 0.1% | 55,153 | 3.3M USD | new | Q1 2024 1 quarter |
| ALB Albemarle Corporation | 0.1% | 25,000 | 3.3M USD | new | Q1 2024 1 quarter |
| Lazard Inc | 0.1% | 77,700 | 3.3M USD | new | Q1 2024 1 quarter |
| Ambarella Inc | 0.1% | 60,000 | 3.0M USD | new | Q1 2024 1 quarter |
| Chemours Co | 0.1% | 112,348 | 3.0M USD | new | Q1 2024 1 quarter |
| Global X Fds | 0.1% | 100,000 | 2.9M USD | new | Q1 2024 1 quarter |
| Dynex Cap Inc | 0.1% | 214,626 | 2.7M USD | new | Q1 2024 1 quarter |
| ECHO EchoStar | 0.1% | 187,383 | 2.7M USD | new | Q1 2024 1 quarter |
| 4D Molecular Therapeutics In | < 0.1% | 62,500 | 2.0M USD | new | Q1 2024 1 quarter |
| EQT EQT Corporation | < 0.1% | 50,001 | 1.9M USD | new | Q1 2024 1 quarter |
| Stevanato Group S P A | < 0.1% | 45,000 | 1.4M USD | new | Q1 2024 1 quarter |
| Crescent Energy Company | < 0.1% | 99,990 | 1.2M USD | new | Q1 2024 1 quarter |
| Spyre Therapeutics Inc | < 0.1% | 30,038 | 1.1M USD | new | Q1 2024 1 quarter |
| NEE NextEra Energy | < 0.1% | 16,904 | 1.1M USD | new | Q1 2024 1 quarter |
| Progress Software Corp | < 0.1% | 14,120 | 752.7K USD | new | Q1 2024 1 quarter |
| SOLV Solventum | < 0.1% | 10,000 | 695.5K USD | new | Q1 2024 1 quarter |
| Madrigal Pharmaceuticals Inc | < 0.1% | 2,016 | 538.4K USD | new | Q1 2024 1 quarter |
| Apellis Pharmaceuticals Inc | < 0.1% | 8,948 | 526.0K USD | new | Q1 2024 1 quarter |
| Ascendis Pharma A/S | < 0.1% | 3,432 | 518.8K USD | new | Q1 2024 1 quarter |
| Sarepta Therapeutics Inc | < 0.1% | 3,956 | 512.1K USD | new | Q1 2024 1 quarter |
| Boundless Bio Inc | < 0.1% | 20,000 | 285.0K USD | new | Q1 2024 1 quarter |
| United Therapeutics Corp Del | < 0.1% | 1,054 | 242.1K USD | new | Q1 2024 1 quarter |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Plus 29 option positions, value of the underlying shares as reported 1.7B USD – not included in the weights.
The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.
- Invesco QQQ TR Put 379.6M USD
- Ishares TR Put 194.3M USD
- Cloudflare Put 145.2M USD
- Ishares TR Call 94.6M USD
- SPDR S&P 500 ETF TR Put 91.5M USD
- SPDR Ser TR Put 83.7M USD
- Ishares Inc Put 71.4M USD
- Ishares TR Call 63.1M USD
- Alibaba Group (ADR) Call 54.3M USD
- Synchrony Financial Put 53.9M USD
Plus 29 positions in convertible bonds and bonds worth 1.7B USD as reported – not included in the weights.
Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.
- Rivian Automotive Inc principal 191.4M USD 154.2M USD
- Microstrategy Inc principal 31.3M USD 134.2M USD
- Digitalocean HLDGS Inc principal 154.0M USD 129.9M USD
- Wayfair Inc principal 137.5M USD 127.2M USD
- Microstrategy Inc principal 90.0M USD 123.1M USD
- Dish Network Corporation principal 138.3M USD 100.2M USD
- Peloton Interactive Inc principal 117.5M USD 100.0M USD
- Dropbox Inc principal 90.8M USD 86.3M USD
- Wolfspeed Inc principal 135.5M USD 77.2M USD
- Lumentum HLDGS Inc principal 81.3M USD 71.6M USD
Breakdown by sector
- Communication Services 8.9%
- Consumer Discretionary 8.8%
- Industrials 8.3%
- Financials 4.1%
- Technology 3.3%
- Materials 3.3%
- Health Care 3.1%
- Utilities 1.6%
- Energy 0.4%
- Consumer Staples 0.2%
- not in our coverage 58.2%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors